Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
237.60
+24.60 (11.55%)
At close: Apr 24, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22
Generic Drugs
582.36M---
Pharmaceuticals
-466.68M316.63M212.47M
Pharmaceuticals Growth
-47.39%49.03%-
Total
582.36M466.68M316.63M212.47M
Total Growth
24.79%47.39%49.03%-

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Mainland China
466.68M316.63M212.47M
Mainland China Growth
47.39%49.03%-
Total
466.68M316.63M212.47M
Total Growth
47.39%49.03%-
Source: S&P Global Market Intelligence.